MD, MSc, FASCO
Richard M. Goldberg Distinguished Professor in Medical Oncology
Professor of Public Health, Health Policy and Management, Gillings School of Global Public Health
Co-Leader, UNC Lineberger Cancer Prevention and Control Research Program
Director, Cancer Outcomes Research Program
Chief of Oncology
UNC-Chapel Hill
Cancer Prevention and Control
Meet Ethan Basch
Area of Interest
Awards and Honors
- Elected to Board of Directors, American Society of Clinical Oncology (ASCO), 2019
- Elected to the American Society for Clinical Investigation (ASCI), 2018
- Awarded the Ware/Tarlov Career Achievement Prize in Patient-Reported Outcomes Measures, Health Assessment Labs, 2017
- Ware/Tarlov Career Achievement Prize, 2017
- Visiting Scholar, University of Birmingham, England, 2017
- Visiting Scholar, Dartmouth University, 2016
- Appointee, Board of Scientific Advisors, National Cancer Institute, 2012
- Visiting Professor, Johns Hopkins School of Medicine, 2012
- Board of Directors, International Society for Quality of Life Research, 2011
- Federal Appointee, Patient-Centered Outcomes Research Institute (PCORI), Methodology Committee, 2011
- Career Development Award, American Society of Clinical Oncology, 2006
- Research Investigator Award, Cancer and Leukemia Group B, 2004
- Carbone Young Investigator Award, Geriatric Oncology Consortium, 2004
- Merit Awards, American Society of Clinical Oncology, 2004-2006
- Collins Research Award, Harvard Medical School, 1997
- Lally Research Scholarship, Harvard University, 1996
- Albert Schweitz Fellowship, 1996
- Fulbright Scholarship, 1989
- Baker Research Fellowship, Brown University, 1989
- Phi Beta Kappa, Magna cum laude, 1989
News and Stories
Basch receives $3 million research award to launch national patient-reported outcomes project
PCORI has awarded Ethan Basch, MD, MSc, FASCO, research funding to support a multi-institutional initiative to implement electronic patient-reported outcomes in oncology practices across the country.
Study provides guidance on quality-of-life choices for rectal cancer treatments
A multi-institutional study comparing treatment options for locally advanced rectal cancer while collecting patient-reported treatment side-effects has generated insights patients can use to make more informed quality-of-life treatment choices.
Using telehealth to regularly report symptoms improved overall well-being for patients with advanced cancer
Ethan Basch, MD, MSc, FASCO, reports that people with advanced cancer who reported their symptoms weekly using an electronic survey had better outcomes compared to those who were evaluated less frequently via in-person clinical visits.
UNC Lineberger faculty present research at the American Society of Clinical Oncology annual meeting
UNC Lineberger members will be presenting research findings, providing commentary and leading education sessions at the American Society of Clinical Oncology’s 58th annual meeting.
